#USA #San Francisco #J.P. Morgan #biotechnology #BIOSeedin

BIOSeedin Winter Innovation Partnering Summit 2026

The BIOSeedin Winter Innovation Partnering Summit served as a pivotal event during J.P. Morgan Healthcare Week, taking place in San Francisco on January 11, 2026. This annual summit particularly focused on a unique aspect dubbed the 'China Asset Showcase.' The intent was to establish a global platform for showcasing innovative Chinese pharmaceuticals and facilitating licensing collaborations, ensuring that Chinese biotech firms effectively connect their resources worldwide.

The summit was attended by over 500 industry representatives from more than ten countries and regions. It successfully brought together multinational corporations, leading pharmaceutical and biotech companies, as well as top-tier investment institutions from across the entire industry spectrum. The event facilitated more than 300 one-on-one meetings and featured 18 special tours of innovative Chinese biotech firms, all occurring within a vibrant atmosphere that fostered enthusiastic exchanges and strong collaborative intentions. This perfectly encapsulated its international vision and industrial integration capabilities.

Three cross-border roundtable discussions were held, where seasoned business development professionals and industry leaders delved into pressing topics such as oncology, cardio-renal and metabolic diseases (CRM), and autoimmune conditions. The discussions highlighted various insights, including national therapies tailored for high-incidence cancers, AI-accelerated clinical trials in CRM, and multifaceted priorities for Sino-foreign collaboration in autoimmune diseases. The 18 Chinese biotech firms presented high-quality assets in advanced fields such as bispecific antibodies, Antibody-Drug Conjugates (ADCs), and molecular glues, aligning with industry hotspots and showcasing successful R&D achievements in niche sectors.

This summit successfully gathered pioneering global insights, activated interregional and interindustry cooperation, and built a professional bridge for internationalizing innovative Chinese medicines. Looking forward, BIOSeedin is committed to leveraging the advantages of its platform and organizing high-quality industry events. Additionally, it aims to collaborate with global partners to explore investment opportunities and collectively shape the future of biopharmaceutical innovation.

BIOSeedin looks forward to meeting you at the next conference, where discussions will focus on exploring investment opportunities, forging transformative partnerships, and shaping the future blueprint of biopharmaceutical innovation. Stay connected with us at www.bioseedin.com for more updates.